Briefings in Bioinformatics,
Год журнала:
2024,
Номер
26(1)
Опубликована: Ноя. 22, 2024
Abstract
Accurate
prediction
of
binding
between
human
leukocyte
antigen
(HLA)
class
I
molecules
and
antigenic
peptide
segments
is
a
challenging
task
key
bottleneck
in
personalized
immunotherapy
for
cancer.
Although
existing
tools
have
demonstrated
significant
results
using
established
datasets,
most
can
only
predict
the
affinity
peptides
to
HLA
do
not
enable
immunogenic
interpretation
new
epitopes.
This
limitation
from
training
data
computational
models
relying
heavily
on
large
amount
peptide-HLA
(pHLA)
eluting
ligand
data,
which
candidate
epitopes
lack
immunogenicity.
Here,
we
propose
an
adaptive
immunogenicity
model,
named
MHLAPre,
trained
large-scale
MS-derived
eluted
ligandome
(mostly
presented
by
epitopes)
that
are
immunogenic.
Allele-specific
pan-allelic
also
provided
endogenous
presentation.
Using
meta-learning
strategy,
MHLAPre
rapidly
assessed
affinities
across
whole
pHLA
pairs
accurately
identified
tumor-associated
antigens.
During
process
immune
response
T-cells,
pHLA-specific
presentation
pre-task
CD8+
T-cell
recognition.
The
factor
activating
interaction
complexes
receptors
(TCRs).
Therefore,
performed
transfer
learning
model
pHLA-TCR
dataset.
In
task,
improvement
identifying
neoepitope
compared
with
five
state-of-the-art
models,
proving
its
effectiveness
robustness.
After
exhibited
relatively
superior
performance
revealing
mechanism
immunotherapy.
powerful
tool
identify
neoepitopes
interact
TCR
induce
responses.
We
believe
proposed
method
will
greatly
contribute
clinical
immunotherapy,
such
as
anti-tumor
immunity,
tumor-specific
engineering,
tumor
vaccine.
British Journal of Haematology,
Год журнала:
2025,
Номер
unknown
Опубликована: Янв. 21, 2025
Summary
Acquired
aplastic
anaemia
(AA)
is
an
autoimmune
bone
marrow
failure
disease
resulting
from
a
cytotoxic
T‐cell‐mediated
attack
on
haematopoietic
stem
and
progenitor
cells
(HSPCs).
Despite
significant
progress
in
understanding
the
T‐cell
repertoire
alterations
AA,
identifying
specific
pathogenic
T
AA
patients
has
remained
elusive,
primarily
due
to
unknown
antigenic
targets
of
attack.
In
this
review,
we
will
synthesize
findings
several
decades
research
critically
evaluate
current
knowledge
repertoires
AA.
We
highlight
new
insights
gained
recent
vitro
studies
candidate
autoreactive
isolated
discuss
efforts
identify
shared
clonotypes
Finally,
emerging
evidence
potential
cross‐reactivity
between
HSPC
common
viral
epitopes
that
may
contribute
development
some
patients.
conclude
by
highlighting
areas
consensus
limitations,
as
well
ongoing
uncertainties,
promising
directions
for
future
field.
Correctly
identifying
epitope-binding
T-cell
receptors
(TCRs)
is
important
to
both
understand
their
underlying
biological
mechanism
in
association
some
phenotype
and
accordingly
develop
mediated
immunotherapy
treatments.
Although
the
importance
of
CDR3
region
TCRs
for
epitope
recognition
well
recognized,
methods
profiling
interactions
a
certain
disease
or
remains
less
studied.
We
developed
EpicPred
identify
phenotype-specific
TCR-epitope
interactions.
first
predicts
removes
unlikely
reduce
false
positives
using
Open-set
Recognition
(OSR).
Subsequently,
multiple
instance
learning
was
used
specific
cancer
type
severity
levels
COVID-19
infected
patients.
From
six
public
TCR
databases,
244
552
sequences
105
unique
epitopes
were
predict
filter
out
non-epitope-binding
OSR
method.
The
predicted
further
groups
two
four
TCR-seq
datasets
bulk
single-cell
resolution.
outperformed
competing
predicting
phenotypes,
achieving
an
average
AUROC
0.80
±
0.07.
Software
available
at
https://github.com/jaeminjj/EpicPred.
Frontiers in Immunology,
Год журнала:
2025,
Номер
16
Опубликована: Апрель 8, 2025
T-cell
receptor
(TCR)
repertoires
provide
insights
into
tumor
immunology,
yet
their
variations
across
digestive
system
cancers
are
not
well
understood.
Characterizing
TCR
differences
between
colorectal
cancer
(CRC)
and
gastric
(GC),
as
developing
machine
learning
models
to
distinguish
types,
metastatic
status,
disease
stages
crucial
for
guiding
clinical
practices.
A
cohort
study
of
143
patients
(96
CRC,
47
GC)
was
conducted.
High-throughput
sequencing
performed
capture
beta
(TRB),
delta
(TRD),
gamma
(TRG)
chain
data.
Tissue-specific
patterns
in
repertoire
features,
such
V-J
gene
recombination,
complementarity-determining
region
3
(CDR3)
sequences,
motif
distributions,
were
analyzed.
Multi-layer
learning-based
diagnostic
developed
by
leveraging
motif-based
feature
deep
extraction
using
ProteinBERT
from
the
100
most
abundant
CDR3
sequences
per
sample.
These
used
differentiate
CRC
GC,
primary
lesions,
predict
CRC.
observed
Distinct
recombination
identified,
with
showing
enrichment
TRBV*-TRBJ*
combinations,
while
GC
exhibited
higher
levels
γδT-cell-related
recombination.
Primary
lesions
displayed
distinct
preferences
(e.g.,
TRBV7-9/TRBJ2-1
metastatic;
TRBV20-1/TRBJ1-2
primary)
sequence
differences,
having
shorter
TRG
lengths
(p-value
=
0.019).
Across
stages,
later
(III-IV)
showed
clonal
diversity
<
0.05)
stage-specific
patterns,
alongside
amino
acid
at
N-terminal
(positions
1-2)
central
positions
5-12).
Multi-dimensional
demonstrated
exceptional
performance
all
classification
tasks.
For
distinguishing
model
achieved
an
accuracy
97.9%
area
under
curve
(AUC)
0.996.
differentiating
100%
AUC
1.000.
In
predicting
attained
96.9%
0.993.
Extensive
validation
simulated
publicly
available
datasets,
confirmed
robustness
reliability
models,
demonstrating
consistent
diverse
datasets
experimental
conditions.
Our
investigation
provides
novel
tumors,
highlight
potential
immune
features
powerful
tools
understanding
progression
potentially
improving
decision-making.